Craft

Provexis

Stock Price

£0

2024-10-29

Market Capitalization

£13.1 M

2024-10-29

Revenue

£1.3 M

FY, 2025

Provexis Summary

Company Summary

Overview
Provexis is a research company, developing bioactives for integration into functional foods and beverages. The Company only develops products that have a health benefit which is clearly defined and scientifically proven. Provexis is engaged in developing and licensing the Fruitflow heart-health functional food ingredient for the global functional food sector. Fruitflow is a tomato extract, which inhibits platelet aggregation that causes heart attack, stroke and venous thrombosis. The syrup and powder versions of Fruitflow are used in foods, beverages and supplements.
Type
Public
Status
Active
Founded
1999
HQ
Reading, GB | view all locations
Website
https://www.provexis.com/
Cybersecurity rating
Sectors

Key People

  • Dawson Buck, Executive Chairman

    • Ian Ford, BA (Hons) ACA, Finance Director

      • Frédéric Boned, Non-Executive Director

        LocationsView all

        2 locations detected

        • Reading, England HQ

          United Kingdom

          2 Blagrave St

        • Reading, England

          United Kingdom

          Prospect House 58 Queen's Rd

        Provexis Financials

        Summary Financials

        Revenue (H1, 2026)
        £364.0K
        Gross profit (H1, 2026)
        £169.0K
        Net income (H1, 2026)
        (£310.0K)
        Cash (H1, 2026)
        £523.0K
        EBIT (H1, 2026)
        (£310.0K)

        Footer menu